Pembrolizumab in metastatic castration-resistant prostate cancer: Can an agnostic become a believer? Editorial

  

Author:	Slovin, S. F.
Title:	Pembrolizumab in metastatic castration-resistant prostate cancer: Can an agnostic become a believer?
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	5
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-02-10
Start Page:	381
End Page:	383
Language:	English
DOI:	10.1200/jco.19.02921
PUBMED:	31877088
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079077232&doi=10.1200%2fJCO.19.02921&partnerID=40&md5=4c5ed9e676d9bcc634e57f352f25ae33
Notes:	Editorial -- Export Date: 2 March 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/162064